Loncastuximab (RB4v1.2) is a monoclonal antibody inhibitor targeting CD19 with antitumor activity. It is used in research on non-Hodgkin lymphoma (NHL) and diffuse large B-cell lymphoma (DLBCL), and for synthesizing ADC molecules such as Loncastuximab tesirine.
Purity:
95.90%
CAS Number:
[1875032-68-0]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
